![Figure 2: Mechanism of radiation resistance in H3K27me3-deficient medulloblastoma.](https://www.oncotarget.net/wp-content/uploads/2023/08/Screen-Shot-2023-08-02-at-1.46.19-PM-300x186.png)
Epigenetically Guided Cancer Therapy: Targeting H3K27me3 Loss in Pediatric Brain Tumors
August 2, 2023
our discovery of H3K27me3 as an epigenetic marker of radiation resistance in medulloblastoma has a potential to open new therapeutic avenues [...]”BUFFALO, NY- August 2, 2023 – A new editorial paper... read more